Phase 3 ARISE trial of solengepras, a potential first-in-class non-dopaminergic therapy, is fully enrolled and topline data ...

You can find them at Ivies and at community colleges, at big state schools and small liberal-arts colleges. They are a part ...

The HONOR 600 became available to buy this week, and I have been testing its features that the company says even rivals current flagships.

The 28.3M SF of Class-A industrial space in Philly proper has a nearly 30% vacancy rate, but other parts of the region are ...

Tech upgrades and driveline refinements headline the most extensive facelift in the limousine’s 54-year history ...

Five seniors from Sioux Falls' public schools share stories that show why the path to high school graduation isn't the same ...

Energy harvesting of all types generates significant interest and attention, as it has that aura of getting a little bit of ...

A recent high-profile incident illustrates the growing litigation and regulatory risks that financial institutions face from ...

On track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 for XTX501, a potential best-in-class ...

Regenxbio is pitching at FDA approval next year for its Duchenne muscular dystrophy (DMD) gene therapy RGX-202, after ...

Regenxbio announces positive results from pivotal phase III AFFINITY DUCHENNE study of RGX-202 to treat Duchenne muscular dystrophy: Rockville, Maryland Friday, May 15, 2026, 14:0 ...

The CX-5 updated its screen and improved tight rear legroom to go with its BMW-like handling. But Mazda forgot to bring back ...